NextPlat Corp (NXPL) reports a 66% increase in recurring revenue airtime contracts and strategic expansions, despite facing profit margin pressures and non-recurring expenses.

PAR Technology's transition to a subscription-based model and strategic acquisitions drive significant growth. Read why the ...

Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Q4 2024 Management View CEO Josh Riggs highlighted significant progress in advancing OncoCyte's clinical assay, including the launch of GraftAssure, a research-use-only kidney transplant test. The ...

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu” or the "Company”) (NASDAQ: FUFU), a global leader in ...

Investing.com -- TD Cowen said it has greater confidence in Dayforce Inc (NYSE: DAY) ability to outperform consensus mid-term ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- 17 Education & Technology Group Inc. (NASDAQ: YQ) ("17EdTech” or the "Company”), ...

BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced its unaudited ...

The TSX finished strong last year but tariff threats to start 2025 prevented the market from further advancing. While market ...

In this digital age, in which cybersecurity threats are rapidly evolving, companies that provide digital protection are more ...

The CRN 2025 Partner Program Guide offers the information solution providers need to evaluate the channel programs operated ...